NBC Securities Inc. Raises Stock Holdings in CVS Health Co. (NYSE:CVS)

NBC Securities Inc. increased its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 100,014.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,008 shares of the pharmacy operator's stock after purchasing an additional 7,001 shares during the period. NBC Securities Inc.'s holdings in CVS Health were worth $474,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the business. Whitebox Advisors LLC acquired a new position in CVS Health during the 4th quarter worth approximately $249,000. B&D White Capital Company LLC acquired a new position in shares of CVS Health during the fourth quarter worth approximately $417,000. Fairfax Financial Holdings Ltd. Can bought a new position in shares of CVS Health in the 4th quarter worth $121,742,000. Lazard Asset Management LLC grew its position in CVS Health by 7.3% in the 4th quarter. Lazard Asset Management LLC now owns 4,290,953 shares of the pharmacy operator's stock valued at $192,617,000 after purchasing an additional 293,406 shares during the period. Finally, Seizert Capital Partners LLC increased its stake in CVS Health by 22.8% during the 4th quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator's stock valued at $25,566,000 after purchasing an additional 105,708 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Performance

CVS Health stock traded up $0.53 during mid-day trading on Friday, reaching $63.61. The company's stock had a trading volume of 3,264,199 shares, compared to its average volume of 11,090,212. The firm's fifty day moving average price is $65.30 and its two-hundred day moving average price is $59.84. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $72.51. The company has a market capitalization of $80.47 billion, a P/E ratio of 17.38, a PEG ratio of 0.98 and a beta of 0.56.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.63. The company had revenue of $94.59 billion during the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The firm's quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.31 earnings per share. Sell-side analysts predict that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.18%. The ex-dividend date of this dividend was Tuesday, April 22nd. CVS Health's dividend payout ratio (DPR) is presently 63.48%.

Analyst Upgrades and Downgrades

CVS has been the topic of several recent research reports. Robert W. Baird raised their price target on shares of CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a research report on Tuesday, April 15th. Mizuho increased their price objective on CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Wells Fargo & Company reaffirmed an "overweight" rating and set a $84.00 target price (up previously from $76.00) on shares of CVS Health in a research report on Tuesday, May 6th. Royal Bank of Canada increased their price target on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research report on Monday, May 5th. Finally, Leerink Partnrs raised shares of CVS Health from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 12th. Two analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $74.75.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.